BD (NYSE: BDX) is touting that it is the first medical technology company authorized as a Common Vulnerability and Exposures (CVE) Numbering Authority by the CVE Program.
BD officials say the authorization further boosts the company’s healthcare cybersecurity leadership.
Get the full story on our sister site Medical Design & Outsourcing.
BD (NYSE: BDX) is touting that it is the first medical technology company authorized as a Common Vulnerability and Exposures (CVE) Numbering Authority by the CVE Program.
BD officials say the authorization further boosts the company’s healthcare cybersecurity leadership. Cybersecurity has become a major issue for the medical device industry, with FDA even appointing its first medtech cybersecurity chief this year.
“The CVE Program is the de facto international standard for vulnerability identification and naming,” CVE board member Chris Levendis said in a June 2 news release from BD. “Being authorized as a CVE Numbering Authority demonstrates mature vulnerability management practices and a strong commitment to cybersecurity. By making accurate and timely vulnerability information available, CNAs like BD help their customers streamline early-stage vulnerability management.”
BD has developed a mature Coordinated Vulnerability …